Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.
Clin Cancer Res. 2018 Dec 01;24(23):6098
Authors: Joseph RW, Elassaiss-Schaap J, Kefford R, Hwu WJ, Wolchok JD, Joshua AM, Ribas A, Hodi FS, Hamid O, Robert C, Daud A, Dronca R, Hersey P, Weber JS, Patnaik A, de Alwis DP, Perrone A, Zhang J, Kang SP, Ebbinghaus S, Anderson KM, Gangadhar TC
PMID: 30510087 [PubMed - in process]
from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2rnLSEZ
No comments:
Post a Comment